XML 28 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
Financial Instruments and Fair Value Measurements
9 Months Ended
Jun. 30, 2016
Fair Value Disclosures [Abstract]  
Financial Instruments and Fair Value Measurements
Financial Instruments and Fair Value Measurements
The fair values of financial instruments, including those not recognized on the statement of financial position at fair value, carried at June 30, 2016 and September 30, 2015 are classified in accordance with the fair value hierarchy in the following tables:
 
 
 
Basis of Fair Value Measurement
(Millions of dollars)
June 30, 2016
Total
 
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
 
Significant Other
Observable
Inputs (Level 2)
 
Significant
Unobservable
Inputs (Level 3)
Assets
 
 
 
 
 
 
 
Institutional money market investments
$
404

 
$
404

 
$

 
$

Interest rate swaps
27

 

 
27

 

Forward exchange contracts
12

 

 
12

 

Total Assets
$
442

 
$
404

 
$
39

 
$

Liabilities
 
 
 
 
 
 
 
Forward exchange contracts
$
8

 
$

 
$
8

 
$

Commodity forward contracts
2

 

 
2

 

Interest rate swaps
19

 

 
19

 

Contingent consideration liabilities
53

 

 

 
53

Total Liabilities
$
83

 
$

 
$
30

 
$
53

 
 
 
Basis of Fair Value Measurement
(Millions of dollars)
September 30,
2015
Total
 
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
 
Significant Other
Observable
Inputs (Level 2)
 
Significant
Unobservable
Inputs (Level 3)
Assets
 
 
 
 
 
 
 
Institutional money market investments
$
147

 
$
147

 
$

 
$

Interest rate swaps
19

 

 
19

 

Forward exchange contracts
13

 

 
13

 

Total Assets
$
179

 
$
147

 
$
32

 
$

Liabilities
 
 
 
 
 
 
 
Forward exchange contracts
$
21

 
$

 
$
21

 
$

Commodity forward contracts
10

 

 
10

 

Contingent consideration liabilities
77

 

 

 
77

Total Liabilities
$
108

 
$

 
$
30

 
$
77


The Company’s institutional money market accounts permit daily redemption and the fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions. The Company’s remaining cash equivalents were $1.283 billion and $1.277 billion at June 30, 2016 and September 30, 2015, respectively. Short-term investments are held to their maturities and are carried at cost, which approximates fair value. The cash equivalents consist of liquid investments with a maturity of three months or less and the short-term investments consist of instruments with maturities greater than three months and less than one year.
The Company measures the fair value of forward exchange contracts and interest rate swaps based upon the present value of expected future cash flows using market-based observable inputs including credit risk, interest rate yield curves, foreign currency spot prices and forward prices.
Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments, which are considered Level 2 inputs in the fair value hierarchy. The fair value of long-term debt was $11.4 billion and $11.6 billion at June 30, 2016 and September 30, 2015, respectively. During the first and third quarters of fiscal year 2016, the Company reclassified $500 million of 1.750% notes due on November 8, 2016 and $300 million of 1.450% notes due on May 15, 2017, respectively, from Long-Term Debt to Short-term debt. The fair value of reclassified notes was $802 million and $750 million at June 30, 2016 and September 30, 2015, respectively. The balance of reclassified notes at September 30, 2015, which has been repaid, represented $750 million of floating rate notes due on June 15, 2016.
The contingent consideration liabilities were recognized as part of the consideration transferred by the Company for certain acquisitions. The fair values of the contingent consideration liabilities were estimated using probability-weighted discounted cash flow models that were based upon the probabilities assigned with regard to achievement of the contingent events. The estimated fair values of the contingent consideration liabilities are remeasured each reporting period based upon increases or decreases in the probability of the contingent payments. The change to the contingent consideration liability for the nine months ended June 30, 2016 primarily reflected a net decrease of $26 million, which was recorded in Selling and administrative expense, in the fair value of contingent consideration liabilities associated with certain product development milestones.
The Company’s policy is to recognize any transfers into fair value measurement hierarchy levels and transfers out of levels at the beginning of each reporting period. There were no transfers in and out of Level 1, Level 2 or Level 3 measurements for the three and nine months ended June 30, 2016 and 2015.